Dr. Mallick is a Clinical Associate Professor of Medical Oncology at Thomas Jefferson University, where she serves as Director of the Solid Tumor Division, Enterprise Director for Soft Tissue Sarcoma and Bone Tumor, Enterprise Deputy Director for Pancreatic Cancer, and Director of Inpatient Medical Oncology Services. Over the past 15 years, she has developed broad and deep expertise in the clinical management of rare tumors, multidisciplinary program building, trainee education, and clinical and translational research, with a strong focus on sarcomas, including chondrosarcoma.
She has served as Principal Investigator or Co-Investigator on more than 250 clinical trials, including first-in-human studies, cooperative group trials, and pharmaceutical industry–sponsored protocols across sarcoma and gastrointestinal cancers. Her research interests include metabolomic profiling in chondrosarcoma, molecular characterization of soft tissue sarcoma and chordoma, pharmacogenetics and prognostic markers in gastrointestinal malignancies, and population-based outcomes research in sarcoma and pancreatic adenocarcinoma.
These experiences have provided Dr. Mallick with a strong foundation in clinical trial design, biospecimen-based translational research, and collaborative multi-institutional studies. She is committed to advancing biologically informed, precision-medicine–driven approaches for patients with rare bone tumors, with particular emphasis on improving therapeutic options and biomarker development for chondrosarcoma, where current treatments remain limited.